Find in Library

Background: Previous studies have shown the relationship between respiratory viruses with acute coronary syndromes. However, its relationship with a new virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not clear yet. Aim: Our aim is to investigate the frequency of ST-segment elevation myocardial infarctions (STEMIs) presenting to catheterization laboratories during SARS-CoV-2 pandemic. Methods: As a pilot study, the number of patients with a primary diagnosis of STEMI admitted to the catheterization laboratory with the purpose of primary percutaneous coronary intervention (PCI) between March 15 and April 15, 2020, also known as the 1st month of the pandemic, was determined. This number then has been compared to the same period of 2019 (March 15, 2019, to April 15, 2019). Results: During the pandemic period (March 15, 2020, to April 15, 2020), eight cases were admitted to the catheterization laboratory for primary PCI, due to STEMI. It was determined that 32 patients were admitted to the catheterization laboratory in the same period of 2019 (March 15, 2019, to April 15, 2019). When primary PCI numbers were compared, it was found that there was a 75% decrease in the number of cases. In 2019, the monthly average of STEMI cases was 25 ± 8. Compared to 2019, there was a 65% reduction. Conclusion: We found that, there was a substantial decrease in STEMI cases during pandemic period, at least in the initial phase.